Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. | Mol Neurodegener | 2023 | 37545006 | PubTator, text mining | PubMed |
| Impact of Protein Nα-Modifications on Cellular Functions and Human Health. | Life (Basel) | 2023 | 37511988 | PubTator, text mining | PubMed |
| Homozygous deep intronic variant in SNX14 cause autosomal recessive Spinocerebellar ataxia 20: a case report. | Front Genet | 2023 | 37485342 | PubTator, text mining | PubMed |
| Spinocerebellar ataxia type 8 presents as progressive supranuclear palsy. | Neurosciences (Riyadh) | 2023 | 37482381 | PubTator, text mining | PubMed |
| Disability in cerebellar ataxia syndromes is linked to cortical degeneration. | J Neurol | 2023 | 37480400 | PubTator, text mining | PubMed |
| Autosomal dominant cerebellar ataxias: new genes and progress towards treatments. | Lancet Neurol | 2023 | 37479376 | PubTator, text mining | PubMed |
| User Retention and Engagement in the Digital-Based Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (myDESMOND) Program: Descriptive Longitudinal Study. | JMIR Diabetes | 2023 | 37477963 | PubTator, text mining | PubMed |
| Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma. | PLoS One | 2023 | 37467193 | PubTator, text mining | PubMed |
| Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. | Pancreatology | 2023 | 37460341 | PubTator, text mining | PubMed |
| On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics. | Neural Regen Res | 2023 | 37449627 | PubTator, text mining | PubMed |
| Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP3R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3. | Int J Mol Sci | 2023 | 37445783 | PubTator, text mining | PubMed |
| Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3. | Mol Med | 2023 | 37438701 | PubTator, text mining | PubMed |
| Cyclitols: From Basic Understanding to Their Association with Neurodegeneration. | Nutrients | 2023 | 37432155 | PubTator, text mining | PubMed |
| Neurocognitive and cerebellar function in ADHD, autism and spinocerebellar ataxia. | Front Syst Neurosci | 2023 | 37415926 | PubTator, text mining | PubMed |
| Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease. | Cells | 2023 | 37408238 | PubTator, text mining | PubMed |
| Triplet-primed PCR and Melting Curve Analysis for Rapid Molecular Screening of Spinocerebellar Ataxia Types 1, 2, and 3. | Bio Protoc | 2023 | 37397792 | PubTator, text mining | PubMed |
| Diagnostic utility of movement disorder society criteria for multiple system atrophy. | Front Aging Neurosci | 2023 | 37396656 | PubTator, text mining | PubMed |
| Altered large-scale individual-based morphological brain network in spinocerebellar ataxia type 3. | CNS Neurosci Ther | 2023 | 37392035 | PubTator, text mining | PubMed |
| Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia. | Life (Basel) | 2023 | 37374132 | PubTator, text mining | PubMed |
| Whole Exome Sequencing to Find Candidate Variants for the Prediction of Kidney Transplantation Efficacy. | Genes (Basel) | 2023 | 37372431 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=16